tiprankstipranks
Trending News
More News >
Advertisement

IVOG - ETF AI Analysis

Compare

Top Page

IVOG

Vanguard S&P Mid-Cap 400 Growth ETF (IVOG)

Rating:69Neutral
Price Target:
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) has a solid overall rating, driven by strong contributions from holdings like Curtiss-Wright (CW) and United Therapeutics (UTHR). Both companies demonstrate robust financial performance, positive earnings call results, and stable or bullish trends, which provide a strong foundation for the ETF's performance. However, weaker holdings such as Nutanix (NTNX), with financial instability and bearish technical indicators, may have slightly weighed on the fund's overall rating. Investors should also be mindful of potential risks related to valuation concerns across several holdings.
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Comfort Systems and BWX Technologies, have delivered strong year-to-date performance, supporting overall returns.
Low Expense Ratio
The ETF charges a very low expense ratio compared to industry averages, helping investors keep more of their gains.
Sector Diversification
The fund is spread across multiple sectors, including Industrials, Technology, and Financials, reducing reliance on any single industry.
Negative Factors
High Geographic Concentration
With nearly all assets invested in U.S. companies, the ETF lacks exposure to international markets, limiting diversification.
Mixed Holding Performance
While some top holdings have performed well, others like TransUnion have lagged, potentially dragging on overall returns.
Sector Overweight in Industrials
The ETF has a heavy allocation to Industrials, which could make it vulnerable if this sector faces challenges.

IVOG vs. SPDR S&P 500 ETF (SPY)

IVOG Summary

The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) is an investment fund that focuses on mid-sized U.S. companies with strong growth potential. It follows the S&P MidCap 400 Growth Index, which includes businesses showing high growth in earnings and sales. Some of its top holdings include well-known companies like Pure Storage and United Therapeutics. This ETF is a good option for investors looking to diversify their portfolio and benefit from the growth of innovative mid-cap companies. However, since it focuses on growth stocks, its value can fluctuate significantly with market conditions.
How much will it cost me?The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) has an expense ratio of 0.15%, meaning you’ll pay $1.50 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks the S&P MidCap 400 Growth Index, keeping costs down.
What would affect this ETF?The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which could negatively impact mid-cap growth companies. Regulatory changes or sector-specific disruptions, particularly in technology or healthcare, could also influence the ETF's performance.

IVOG Top 10 Holdings

The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) leans heavily into industrials and technology, with these two sectors making up nearly half of its portfolio. Comfort Systems is a standout performer, rising steadily on strong earnings and growth momentum, while Coherent Corp has also been climbing thanks to robust revenue and strategic expansions. However, Pure Storage and Guidewire are lagging, with valuation concerns and bearish trends weighing on their performance. The fund’s U.S.-centric focus and mid-cap growth tilt position it to capture innovation, but some holdings are struggling to keep pace.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Comfort Systems2.05%$30.77M$33.90B96.35%
75
Outperform
Pure Storage1.85%$27.74M$29.10B66.95%
72
Outperform
Curtiss-Wright1.35%$20.32M$20.14B48.24%
78
Outperform
Twilio1.25%$18.74M$19.34B21.37%
70
Neutral
Coherent Corp1.23%$18.57M$25.69B57.79%
66
Neutral
United Therapeutics1.21%$18.24M$20.67B29.67%
79
Outperform
Guidewire1.18%$17.81M$18.05B5.70%
66
Neutral
BWX Technologies1.18%$17.67M$15.99B35.47%
69
Neutral
Nutanix1.15%$17.29M$12.78B-28.66%
60
Neutral
RB Global1.11%$16.67M$18.23B1.08%

IVOG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
119.13
Positive
100DMA
118.16
Positive
200DMA
112.72
Positive
Market Momentum
MACD
0.11
Negative
RSI
55.92
Neutral
STOCH
93.86
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVOG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 118.50, equal to the 50-day MA of 119.13, and equal to the 200-day MA of 112.72, indicating a bullish trend. The MACD of 0.11 indicates Negative momentum. The RSI at 55.92 is Neutral, neither overbought nor oversold. The STOCH value of 93.86 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IVOG.

IVOG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.35B0.15%
$9.13B0.17%
$7.92B0.18%
$5.12B0.25%
$3.10B0.06%
$2.43B0.15%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IVOG
Vanguard S&P Mid-Cap 400 Growth ETF
120.57
-1.04
-0.86%
IJK
iShares S&P Mid-Cap 400 Growth ETF
IJJ
iShares S&P Mid-Cap 400 Value ETF
XMHQ
Invesco S&P MidCap Quality ETF
IMCG
iShares Morningstar Mid-Cap Growth ETF
MDYG
SPDR S&P 400 Mid Cap Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement